This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: American Cyanamid Company. Active years: 1996-1997.
Company Filing History:
Years Active: 1996-1997
Title: Gary E Walker: Innovator in Beta-3 Selective Adrenergic Agents
Introduction
Gary E Walker is a notable inventor based in Spring Valley, NY (US). He has made significant contributions to the field of pharmacology, particularly in the development of beta-3 selective adrenergic agents. With a total of 2 patents to his name, Walker's work focuses on innovative solutions for antiobesity and antidiabetic treatments.
Latest Patents
Walker’s latest patents include the invention of Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents. This invention is aimed at providing antiobesity and antidiabetic solutions through beta-3 agonists of a specific formula, wherein the substituents are defined in the specification. His work in this area showcases his commitment to advancing medical treatments.
Career Highlights
Gary E Walker is associated with American Cyanamid Company, where he has contributed to various research initiatives. His expertise in pharmacology and innovative thinking has positioned him as a valuable asset in the field.
Collaborations
Walker has collaborated with notable coworkers such as Joseph William Epstein and Gary H Birnberg. These partnerships have further enhanced his research and development efforts in the pharmaceutical industry.
Conclusion
In summary, Gary E Walker is a distinguished inventor whose work in beta-3 selective adrenergic agents has the potential to impact the treatment of obesity and diabetes. His contributions to American Cyanamid Company and collaborations with other professionals highlight his dedication to innovation in pharmacology.